Mass spectrometry-based metabolomics and lipidomics analysis for potential biomarkers of cardiovascular disorders associated with ambient fine particulate matter exposure

Medicine & Life Sciences

1. Metabolomics 100%
2. Lipidomics 92%
3. Air Pollution 78%
4. Biomarkers 58%
5. Particulate Matter 54%
6. Environmental Pollutants 51%
7. Cardiovascular Diseases 49%
8. Mass Spectrometry 40%
9. Heart 29%
10. Polycyclic Aromatic Hydrocarbons 29%
11. Metabolic Networks and Pathways 22%
12. Cardiovascular System 22%
13. Toxicology 22%
14. Epidemiologic Studies 18%
15. Risk Assessment 18%
16. Air 18%
17. Animal Models 16%
18. Mortality 11%
19. Animals 11%